The Marketing Machine

BioDelivery Sciences to present at the OneMedForum Emerging Company Finance Conference

January 05, 2010 By: NCTechNews Category: Biotechnology

(Raleigh, N.C.) BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that Dr. Mark A. Sirgo, President and Chief Executive Officer, will be presenting at the OneMedForum Emerging Company Finance Conference to be held January 12-13, 2010, at The Sir Francis Drake Hotel, San Francisco.

BioDelivery Sciences’ presentation is scheduled for Tuesday, January 12, at 10:15 AM Pacific Time.

Dr. Sirgo will be providing an update on the October 2009 commercial launch of ONSOLIS (fentanyl buccal soluble film) as well as an update on BDSI’s product pipeline, which includes the recently announced positive topline Phase 2 data on BDSI’s BEMA Buprenorphine and two additional BEMA-formulated product candidates recently added to the development portfolio. Dr. Sirgo will also discuss anticipated milestones for 2010.

The presentation will be webcast live and can be accessed at www.biodeliverysciences.com. For those who are not available to listen to the live broadcast, the presentation will be archived.

BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. BDSI is focusing on developing products to meet unmet needs in the areas of pain management and oncology supportive care. BDSI’s pain franchise currently consists of two products utilizing the Company’s patented BEMA buccal soluble film technology: ONSOLIS (fentanyl buccal soluble film) which was approved by FDA on July 16, 2009, for the management of breakthrough pain in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain, and BEMA Buprenorphine, an analgesic in Phase 2 clinical development with at least one potential target indication for the treatment of moderate to severe pain. Additional product candidates are being developed utilizing the BEMA technology for conditions such as nausea/vomiting and migraine. The Company is also working with its patented Bioral cochleate technology to facilitate oral dosing of drugs otherwise given by intravenous administration. The first product under development using the technology is Bioral Amphotericin B. The Company’s headquarters is located in Raleigh, North Carolina. For more information please visit www.biodeliverysciences.com.

Comments are closed.

← New interactive map shines spotlight on RTP product design and prototyping resources
LabCorp scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference →

  • Packaging Cures
    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus
    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

    Video: QC in Pharma Mfg


    Defense Industry Gets More Competitive
    U.S. troop level decreases and shrinking armed forces budgets will lead to increased competition and a change in business operations for military contractors in North Carolina and throughout the nation, according to defense industry contracting expert Lea Strickland, requiring a more strategic and tactical approach to developing professional, properly-designed bid proposals.

    A Leg Up for Students
    Innovative concept-to-marketplace product design and development firm Montie Design is holding a Winter 2012 Student Design Contest for aspiring product designers in community colleges, four-year colleges, or high schools from North Carolina and Virginia, starting February 1.

    getting from lab 2 line
    The leader in analytical instrumentation for the pharma manufacturing industry has named a new COO responsible for manufacturing, engineering, software development, and project management for hardware and software products such as the VTT-1000 multi-variant testing device, breaking down barriers to speeding-up the drug manufacturing pipeline and cutting-down on drug shortages.

  • Recent Headlines

















free web site traffic and promotion